Artículos del autor

solaci

Acute coronary syndromes

When is the Ideal Timing for NSTE-ACS Percutaneous Intervention?

According to the European Society of Cardiology (ESC Guidelines 2021) an early invasive strategy is recommended (<24h)...
solaci -
Coronary disease

Should We Start Thinking Again About Bioresorbable Stents?

Coronary revascularization with drug-eluting stents (DES) is very frequent, especially in acute coronary syndromes, but these metallic...
solaci -
Institutional News

Save the date Only 2 months for the SOLACI-SOCIME 2022 Congress

August is the month in which we meet again to continue developing interventional cardiology on the continent. Discover...
solaci -
Other

A Nod to Catheter-Guided Thrombolysis in Pulmonary Thromboembolism

Pulmonary thromboembolism (PTE) is the third most frequent cardiovascular disease, with an increasing prevalence over time. The...
solaci -
Mitral valve

Post-MitraClip Mitral Valve Stenosis: Bad Prognosis

The EVEREST II trial has shown the MitraClip has similar mortality rate to that of surgery and,...
solaci -
Structural heart disease

New-Generation ACURATE Neo2

Transcatheter aortic valve replacement (TAVR) is a therapeutical option for patients with symptomatic severe aortic stenosis. Current...
solaci -
Mitral valve

MitraClip Reduces Renal Function Deterioration

Severe mitral regurgitation is associated to cardiac failure and hospitalization and over time is accompanied by kidney...
solaci -
Structural heart disease

TAVR: If Not Transfemoral, We Should Consider Transcaval Access

Transcatheter aortic valve replacement (TAVR) through transfemoral access has already proven its great benefits, but this access...
solaci -